WJ
William P Murphy Jr
Director

William P Murphy Jr insider trades: U.S. Stem Cell (USRM) stock purchases

Director, U.S. Stem Cell Last trade Aug 17, 2017 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2009
3
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 17, 2017USRM↑ Buy$50K
Mar 6, 2017BHRT.OB↑ Buy$24K
Nov 10, 2015BHRT.OB↑ Buy$1K
Oct 27, 2015BHRT.OB↑ Buy$480
Oct 16, 2015BHRT.OB↑ Buy$1K
Oct 9, 2015BHRT.OB↑ Buy$910
Oct 6, 2015BHRT.OB↑ Buy$279
May 18, 2015BHRT.OB↑ Buy$20K
Jul 29, 2011BHRT↑ Buy$100K
Nov 30, 2010BHRT.OB↑ Buy$924K
Feb 26, 2010BHRT.OB↑ Buy$52K
Jul 1, 2009BHRT↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About William P Murphy Jr's insider trades

William P Murphy Jr is a director at U.S. Stem Cell (USRM). Since Jul 1, 2009, William has reported 12 open-market purchases worth $1.3M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (16 filings), conversions (5 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every USRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.